GL検索 v0.1.0
画像は 131 ページを描画したものです
page 131

p.131 抽出テキスト

stents versus bare metal stents prior to noncardiac surgery. Catheter Cardiovasc Interv 2015; 85: 533-541. PMID: 25059742 465. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/ SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation 2016; 134: e123-e155. PMID: 27026020 466. Berger PB, Kleiman NS, Pencina MJ, et al. EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 2010; 3: 920-927. PMID: 20850090 467. Kirtane AJ, Stone GW. How to minimize stent thrombosis. Circulation 2011; 124: 1283-1287. PMID: 21911796 468. Diamantis T, Tsiminikakis N, Skordylaki A, et al. Alterations of hemostasis after laparoscopic and open surgery. Hematology 2007; 12: 561-570. PMID: 17852431 469. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316-328. PMID: 17650517 470. Baschin M, Selleng S, Hummel A, et al. Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study. J Thromb Haemost 2018; 16: 709-717. PMID: 29383871 471. Trenk D, Hille L, Leggewie S, et al. Antagonizing P 2 Y 1 2 Receptor Inhibitors: Current and Future Options. Thromb Haemost 2019; 119: 1606-1616. PMID: 31408901 472. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: Disease prevalence and number of candidates for transcatheter aortic valve replacement: A meta-analysis and modeling study. J Am Coll Cardiol 2013; 62: 1002-1012. PMID: 23727214 473. Yamamoto M, Watanabe Y, Tada N, et al. OCEAN-TAVI investigators. Transcatheter aortic valve replacement outcomes in Japan: Optimized CathEter vAlvular iNtervention (OCEAN) Japanese multicenter registry. Cardiovasc Revasc Med 2019; 20: 843-851. PMID: 30553819 474. Takimoto S, Saito N, Minakata K, et al. Favorable Clinical Outcomes of Transcatheter Aortic Valve Implantation in Japanese Patients: First Report From the Post-Approval K-TAVI Registry. Circ J 2016; 81: 103-109. PMID: 27916776 475. Inoue S, Nakao K, Hanyu M, et al. Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment. Value Health Reg Issues 2020; 21: 82-90. PMID: 31670112 476. Orimo H, Yaegashi Y, Hosoi T, et al. Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trends. Osteoporos Int 2016; 27: 1777-1784. PMID: 26733376 477. Loxdale SJ, Sneyd JR, Donovan A, et al. The role of routine pre-operative bedside echocardiography in detecting aortic stenosis in patients with a hip fracture. Anaesthesia 2012; 67: 51-54. PMID: 22023667 478. 日本整形外科学会 / 日本骨折治療学会 監修. 大腿骨頚部/ 転子部骨折診療ガイドライン2021 改訂第3 版. 南江堂 2021. 479. Orosz GM, Magaziner J, Hannan EL, et al. Association of timing of surgery for hip fracture and patient outcomes. JAMA 2004; 291: 1738-1743. PMID: 15082701 480. OʼBrien SM, Feng L, He X, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 2 — Statistical Methods and Results. Ann Thorac Surg 2018; 105: 1419-1428. PMID: 29577924 481. Mounet B, Choquet O, Swisser F, et al. Impact of multiple nerves blocks anaesthesia on intraoperative hypotension and mortality in hip fracture surgery intermediate-risk elderly

patients: A propensity score-matched comparison with spinal and general anaesthesia. Anaesth Crit Care Pain Med 2021; 40: 100924. PMID: 34217841 482. Leibowitz D, Rivkin G, Schiffman J, et al. Effect of severe aortic stenosis on the outcome in elderly patients undergoing repair of hip fracture. Gerontology 2009; 55: 303- 306. PMID: 19287130 483. Rostagno C, Ranalli C, Polidori G, et al. Outcome in elderly patients with aortic stenosis undergoing hip fracture surgery. Results may suggest a different postoperative strategy? Trauma Surg Acute Care Open 2019; 4: e000218. PMID: 30729173 484. 日本整形外科学会プロジェクト研究事業:大腿骨近位部骨折全国調査結果 2018 年発生例調査結果. 485. Sheehan KJ, Williamson L, Alexander J, et al. Prognostic factors of functional outcome after hip fracture surgery: a systematic review. Age Ageing 2018; 47: 661- 670. PMID: 29668839 486. Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ 2000; 320: 341-346. PMID: 10657327 487. Hagino H. Fragility fracture prevention: Review from a Japanese perspective. Yonago Acta Med 2012; 55: 21-28. PMID: 24031136 488. Sasabuchi Y, Matsui H, Lefor AK, et al. Timing of surgery for hip fractures in the elderly: A retrospective cohort study. Injury 2018; 49: 1848-1854. PMID: 30097309 489. Sakamoto K, Nakamura T, Hagino H, et al. Report on the Japanese Orthopaedic Associationʼs 3-year project observing hip fractures at fixed-point hospitals. J Orthop Sci 2006; 11: 127-134. PMID: 16568383 490. Panula J, Pihlajamäki H, Mattila VM, et al. Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord 2011; 12: 105. PMID: 21599967 491. HIP ATTACK Investigators. Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial. Lancet 2020; 395: 698- 708. PMID: 32050090 492. Hagino H, Endo N, Harada A, et al. Survey of hip fractures in Japan: Recent trends in prevalence and treatment. J Orthop Sci 2017; 22: 909-914. PMID: 28728988 493. Roberts KC, Brox WT. AAOS Clinical Practice Guideline: Management of Hip Fractures in the Elderly. J Am Acad Orthop Surg 2015; 23: 138-140. PMID: 25624366 494. Health Quality Ontario & Ministry of Health and Long-Term Care. Quality-Based Procedures Clinical Handbook for Hip Fracture. 2013. https://health.gov.on.ca/en/pro/programs/ecfa/ docs/qbp_hipfracture.pdf 495. Mak JC, Cameron ID, March LM. Evidence-based guidelines for the management of hip fractures in older persons: an update. Med J Aust 2010; 192: 37-41. PMID: 20047547 496. Rechenmacher SJ, Fang JC. Bridging Anticoagulation: Primum Non Nocere. J Am Coll Cardiol 2015; 66: 1392- 1403. PMID: 26383727 497. Smoyer-Tomic K, Siu K, Walker DR, et al. Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation. Am J Cardiovasc Drugs 2012; 12: 403-413. PMID: 23006024 498. Billett HH, Scorziello BA, Giannattasio ER, et al. Low molecular weight heparin bridging for atrial fibrillation: Is VTE thromboprophylaxis the major benefit? J Thromb Thrombolysis 2010; 30: 479-485. PMID: 20405168 499. Ahmed I, Gertner E, Nelson WB, et al. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm 2010; 7: 745-749. PMID: 20176137 500. Vidán MT, Sánchez E, Alonso M, et al. An intervention integrated into daily clinical practice reduces the incidence of delirium during hospitalization in elderly patients. J Am Geriatr Soc 2009; 57: 2029-2036. PMID: 19754498 501. 浦部晶夫,島田和幸,川合眞一,他編.今日の治療薬2021:解説と便覧.南江堂 2021. 502. 医学通信社 編.DPC 点数早見表 2020 年4 月版.医学通信社2020. 503. van der Pol S, Jacobs MS, Meijer K, et al. Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits. Europace 2019; 21: 716-723. PMID: 30649301